DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
96	クローン病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04112212 (ClinicalTrials.gov)	November 4, 2020	25/9/2019	NIR FME of Labelled Vedolizumab to Elucidate the Mechanism of Action and Predicting Response in IBD Patients.	Near-infrared Fluorescence Molecular Endoscopy Imaging of Labelled Vedolizumab-800CW to Elucidate the Mechanism of Action and Predicting Response in IBD Patients. A Prospective Pilot Intervention Study:	Crohn Disease;Colitis, Ulcerative	Drug: Vedolizumab-800CW;Device: Fluorescence endoscopy and spectroscopy	University Medical Center Groningen	NULL	Recruiting	18 Years	N/A	All	35	Phase 1	Netherlands

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04112212
(ClinicalTrials.gov)

November 4, 2020

25/9/2019

NIR FME of Labelled Vedolizumab to Elucidate the Mechanism of Action and Predicting Response in IBD Patients.

Near-infrared Fluorescence Molecular Endoscopy Imaging of Labelled Vedolizumab-800CW to Elucidate the Mechanism of Action and Predicting Response in IBD Patients. A Prospective Pilot Intervention Study:

Crohn Disease;Colitis, Ulcerative

Drug: Vedolizumab-800CW;Device: Fluorescence endoscopy and spectroscopy

University Medical Center Groningen

NULL

Recruiting

18 Years

N/A

All

Phase 1

Netherlands